Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
Clinical trial NCT05697809 · COMPLETED
Trial details
- NCT number
- NCT05697809
- Sponsor
- Oxular Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-07
- Primary completion
- 2024-12-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.